These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 233695)
1. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. Marx SJ; Spiegel AM; Brown EM; Gardner DG; Downs RW; Attie M; Hamstra AJ; DeLuca HF J Clin Endocrinol Metab; 1978 Dec; 47(6):1303-10. PubMed ID: 233695 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK; Lyles KW; Haussler MR; Harrelson JM J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [TBL] [Abstract][Full Text] [Related]
3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [TBL] [Abstract][Full Text] [Related]
4. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. Balsan S; Garabédian M; Larchet M; Gorski AM; Cournot G; Tau C; Bourdeau A; Silve C; Ricour C J Clin Invest; 1986 May; 77(5):1661-7. PubMed ID: 3009551 [TBL] [Abstract][Full Text] [Related]
5. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475 [TBL] [Abstract][Full Text] [Related]
6. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Yagi H; Ozono K; Miyake H; Nagashima K; Kuroume T; Pike JW J Clin Endocrinol Metab; 1993 Feb; 76(2):509-12. PubMed ID: 8381803 [TBL] [Abstract][Full Text] [Related]
7. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. Glorieux FH; Marie PJ; Pettifor JM; Delvin EE N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463 [TBL] [Abstract][Full Text] [Related]
8. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. Carey DE; Drezner MK; Hamdan JA; Mange M; Ahmad MS; Mubarak S; Nyhan WL J Pediatr; 1986 Dec; 109(6):994-1000. PubMed ID: 3023599 [TBL] [Abstract][Full Text] [Related]
9. Hypercalciuric hypophosphatemic rickets, mineral balance, bone histomorphometry, and therapeutic implications of hypercalciuria. Chen C; Carpenter T; Steg N; Baron R; Anast C Pediatrics; 1989 Aug; 84(2):276-80. PubMed ID: 2787497 [TBL] [Abstract][Full Text] [Related]
10. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets. Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF Am J Dis Child; 1980 Feb; 134(2):140-3. PubMed ID: 6243443 [TBL] [Abstract][Full Text] [Related]
11. Hereditary resistance to 1,25-dihydroxyvitamin D. Marx SJ; Liberman UA; Eil C; Gamblin GT; DeGrange DA; Balsan S Recent Prog Horm Res; 1984; 40():589-620. PubMed ID: 6091196 [No Abstract] [Full Text] [Related]
12. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745 [TBL] [Abstract][Full Text] [Related]
13. Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II). Liberman UA; Eil C; Marx SJ Adv Exp Med Biol; 1986; 196():391-406. PubMed ID: 3012981 [No Abstract] [Full Text] [Related]
14. Effects of vitamin D2 analogs on calcium metabolism in vitamin D-deficient rats and in MC3T3-E1 osteoblastic cells. Sato F; Ouchi Y; Okamoto Y; Kaneki M; Nakamura T; Ikekawa N; Orimo H Res Exp Med (Berl); 1991; 191(4):235-42. PubMed ID: 1788469 [TBL] [Abstract][Full Text] [Related]
15. Effect of 1,25-dihydroxyvitamin D3 treatment on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. Ecarot B; Glorieux FH; Desbarats M; Travers R; Labelle L J Bone Miner Res; 1995 Mar; 10(3):424-31. PubMed ID: 7785464 [TBL] [Abstract][Full Text] [Related]
16. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D: documentation and effective therapy with high dose intravenous calcium infusions. Bliziotes M; Yergey AL; Nanes MS; Muenzer J; Begley MG; Vieira NE; Kher KK; Brandi ML; Marx SJ J Clin Endocrinol Metab; 1988 Feb; 66(2):294-300. PubMed ID: 2828407 [TBL] [Abstract][Full Text] [Related]
17. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII). al-Aqeel A; Ozand P; Sobki S; Sewairi W; Marx S Clin Endocrinol (Oxf); 1993 Aug; 39(2):229-37. PubMed ID: 8396512 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia. Lyles KW; Harrelson JM; Drezner MK J Clin Endocrinol Metab; 1982 Feb; 54(2):307-15. PubMed ID: 6976353 [No Abstract] [Full Text] [Related]
19. Vitamin D metabolism in women with femoral neck fracture. Hordon LD; Peacock M Bone Miner; 1987 Aug; 2(5):413-26. PubMed ID: 2851340 [TBL] [Abstract][Full Text] [Related]
20. Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3. Cundy T; Kanis JA; Heynen G; Earnshaw M; Clemens TL; O'Riordan JL; Merrett AL; Compston JE Br Med J (Clin Res Ed); 1982 Mar; 284(6319):883-5. PubMed ID: 6279228 [No Abstract] [Full Text] [Related] [Next] [New Search]